BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumai T, Yamaki H, Kono M, Hayashi R, Wakisaka R, Komatsuda H. Antitumor Peptide-Based Vaccine in the Limelight. Vaccines (Basel) 2022;10:70. [PMID: 35062731 DOI: 10.3390/vaccines10010070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim S, Park J, Lee S, Lee H, Jung J, Lee Y, Cho H, Kim J, Kim K, Park C, Lee C. Efficient anti-tumor immunotherapy using tumor epitope-coated biodegradable nanoparticles combined with polyinosinic-polycytidylic acid and an anti-PD1 monoclonal antibody.. [DOI: 10.21203/rs.3.rs-2043402/v1] [Reference Citation Analysis]
2 Lath A, Santal AR, Kaur N, Kumari P, Singh NP. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnol Genet Eng Rev 2022;:1-40. [PMID: 35699384 DOI: 10.1080/02648725.2022.2082157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim S, Park J, Lee S, Lee H, Jung J, Lee Y, Cho H, Kim J, Kim K, Park C, Lee C. Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody. Immune Netw 2022;22. [DOI: 10.4110/in.2022.22.e42] [Reference Citation Analysis]